Literature DB >> 21067057

Leprosy and HIV, where are we at?

Diana N J Lockwood, Saba M Lambert.   

Abstract

The impact of leprosy and HIV co-infection is an evolving picture. Surprisingly the outcomes that were feared, of more lepromatous disease has not materialised. But with the roll-out of antiretroviral therapy, the emergence of leprosy as Immune Reconstitution Inflammatory Syndrome is re-focusing attention on the characteristics of this important co-infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067057

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  3 in total

1.  Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment.

Authors:  Madeline Bilodeau; Stephanie Burns; John Gawoski; Samuel Moschella; Winnie Ooi
Journal:  Am J Trop Med Hyg       Date:  2013-08-26       Impact factor: 2.345

2.  Concurrent pulmonary tuberculosis and lepromatous leprosy in a newly diagnosed HIV positive patient: a case report.

Authors:  Josiah T Masuka; Zamambo Mkhize; Somasundram Pillay; Anisa Mosam
Journal:  BMC Pulm Med       Date:  2021-06-30       Impact factor: 3.317

3.  Leprosy Reactions in Patients Coinfected with HIV: Clinical Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil.

Authors:  Carla Andréa Avelar Pires; Fernando Octávio Machado Jucá Neto; Nahima Castelo de Albuquerque; Geraldo Mariano Moraes Macedo; Keila de Nazaré Madureira Batista; Marília Brasil Xavier
Journal:  PLoS Negl Trop Dis       Date:  2015-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.